Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bowen

Showing results (451-460 of 454) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 454 results.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence|February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 46

Showing results (451-460 of 454) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 454 results.
NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
NEJM Evidence|February 6, 2024
Anticoagulation Strategies in Non-Critically Ill Patients with Covid-19Zoe K McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 46